Total Payments
$340,952
2021 Payments
$11,070
Companies
20
Transactions
454
Payment Breakdown by Category
Other$155,105 (45.5%)
Research$75,371 (22.1%)
Travel$54,128 (15.9%)
Consulting$47,130 (13.8%)
Food & Beverage$9,095 (2.7%)
Education$124.13 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $138,180 | 45 | 40.5% |
| Unspecified | $75,371 | 29 | 22.1% |
| Travel and Lodging | $54,128 | 104 | 15.9% |
| Consulting Fee | $47,130 | 17 | 13.8% |
| Honoraria | $16,925 | 7 | 5.0% |
| Food and Beverage | $9,094 | 248 | 2.7% |
| Education | $124.13 | 4 | 0.0% |
Payments by Type
General
$265,581
425 transactions
Research
$75,371
29 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $145,697 | 243 | $0 (2021) |
| Lupin Inc. | $72,618 | 12 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39,744 | 48 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $35,321 | 13 | $0 (2017) |
| CSL Behring | $22,257 | 29 | $0 (2019) |
| Greer Laboratories, Inc. | $21,409 | 35 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $2,437 | 15 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $533.72 | 19 | $0 (2019) |
| PFIZER INC. | $312.29 | 5 | $0 (2018) |
| Shire North American Group Inc | $164.36 | 10 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11,070 | 5 | GlaxoSmithKline, LLC. ($11,070) |
| 2020 | $11,792 | 10 | GlaxoSmithKline, LLC. ($11,792) |
| 2019 | $107,500 | 136 | GlaxoSmithKline, LLC. ($101,372) |
| 2018 | $125,905 | 143 | Lupin Inc. ($72,618) |
| 2017 | $84,686 | 160 | Merck Sharp & Dohme Corporation ($35,321) |
All Payment Transactions
454 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/15/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,175.00 | General |
| 08/05/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $670.00 | General |
| 04/06/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,275.00 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: RESPIRATORY | ||||||
| 01/05/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: RESPIRATORY | ||||||
| 04/28/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $100.43 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $1,069.38 | General |
| Category: RESPIRATORY | ||||||
| 03/24/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $582.20 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $786.80 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $192.24 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $35.71 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | Cash or cash equivalent | $36.73 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $488.19 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $631.00 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $164.68 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $83.06 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $730.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, CROSSOVER, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE DAILY ADMINISTRATION OF LUPIN TIOTROPIUM BROMIDE INHALATION POWDER COMPARED TO SPIRIVA HANDIHALER AND PLACEBO IN PATIENTS WITH COPD INCLUDING A 12-WEEK OPEN LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $70,118 | 11 |
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $2,500 | 1 |
| A RANDOMISED PHIII STUDY TO ASSESS THE EFFECT OF 100 MG SC MEPOLIZUMAB | GlaxoSmithKline, LLC. | $1,237 | 8 |
About Dr. Robert Nathan, MD
Dr. Robert Nathan, MD is a Allergy & Immunology healthcare provider based in Colorado Springs, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487648077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Nathan, MD has received a total of $340,952 in payments from pharmaceutical and medical device companies, with $11,070 received in 2021. These payments were reported across 454 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($138,180).
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Allergy & Immunology
- Location Colorado Springs, CO
- Active Since 09/09/2005
- Last Updated 03/07/2023
- Taxonomy Code 207RA0201X
- Entity Type Individual
- NPI Number 1487648077
Products in Payments
- NUCALA (Biological) $116,000
- TIOTROPIUM (Drug) $70,118
- Haegarda (Biological) $22,257
- Oralair (Drug) $21,409
- SPIRIVA RESPIMAT (Drug) $10,650
- ANORO ELLIPTA (Drug) $8,450
- SPIRIVA (Drug) $7,810
- DULERA (Drug) $3,250
- ADVAIR (Drug) $2,500
- FEVIPIPRANT (Drug) $898.50
- EUCRISA (Drug) $312.29
- FASENRA (Drug) $291.64
- BREO (Drug) $208.32
- SYMBICORT (Drug) $111.79
- BEVESPI AEROSPHERE (Drug) $106.29
- ATOPIC DERMATITIS - DISEASE (Drug) $99.81
- CINRYZE (Drug) $88.97
- ANORO (Drug) $88.86
- TRELEGY ELLIPTA (Drug) $77.08
- CINQAIR (Drug) $66.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Colorado Springs
Mr. Nathanael Brady, D.o, D.O
Allergy & Immunology — Payments: $1.1M
Allergy & Immunology $1.1M
Eric Caplan, M.d, M.D
Allergy & Immunology — Payments: $254,773
Allergy & Immunology $254,773
Jill Hanson, Md, MD
Allergy & Immunology — Payments: $13,812
Allergy & Immunology $13,812
Kevin Meakin, Do, DO
Allergy & Immunology — Payments: $6,053
Allergy & Immunology $6,053
Mrs. Deborah Sweet, Fnp, FNP
Allergy & Immunology — Payments: $2,030
Allergy & Immunology $2,030
Bonnie Baswell, M.d, M.D
Allergy & Immunology — Payments: $850.05
Allergy & Immunology $850.05